University Of Pennsylvania
Clinical trials sponsored by University Of Pennsylvania, explained in plain language.
-
HIV and opioid treatment study halted early – what we know
Disease control TerminatedThis study looked at whether different medications for opioid use disorder (methadone, buprenorphine/naloxone, or naltrexone) could reduce immune system inflammation in people with HIV. Researchers measured changes in blood markers of immune activation over 24 weeks. The trial wa…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Engineered immune cells take on pancreatic cancer in early trial
Disease control TerminatedThis early-phase study tested a treatment called huCART-meso cells, which are a patient's own immune cells modified to recognize and attack pancreatic cancer cells. The trial included 54 people with advanced pancreatic cancer that could not be removed by surgery. The main goal wa…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Heart pump combo tested for shock recovery – trial cut short
Disease control TerminatedThis study tested whether adding an Impella CP heart pump early to standard VA-ECMO support helps people recover from cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. The trial planned to enroll adults with severe heart failure but was term…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New cell therapy targets tough childhood leukemia
Disease control TerminatedThis early-phase study tested a new treatment for children and young adults with acute myeloid leukemia (AML) that returned or didn't respond to standard therapy. The treatment involved taking patients' own immune cells, engineering them to recognize and attack leukemia cells (CA…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Laser zaps root canal bacteria in new study
Disease control TerminatedThis study tested whether a special laser (Er,Cr:YSGG) can kill bacteria in root canals better than the standard rinse. 56 adults undergoing root canal treatment had their canals cleaned with either the laser or standard sodium hypochlorite. Researchers measured bacterial levels …
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Experimental myeloma drug tasquinimod tested in early trial – but study halted
Disease control TerminatedThis early-phase study tested a new drug called tasquinimod, alone or with standard chemotherapy, in 30 adults with multiple myeloma that had relapsed or become resistant. The main goal was to find a safe dose and check for side effects. The trial was terminated early, so results…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New scan could predict hormone therapy success in breast cancer
Diagnosis TerminatedThis study tested a special PET/CT scan using a radioactive tracer called FES to see estrogen receptor activity in women with advanced, hormone-resistant breast cancer. The goal was to see if the scan could predict how well a new hormone therapy would work. Only 6 people were enr…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Mouthwash makeover: can a dental cleanup beat Radiation's painful side effect?
Symptom relief TerminatedThis study tested whether a special oral care routine (dental cleaning and mouth treatment) could reduce severe mouth sores in people getting radiation for head and neck cancer. About 60 adults were planned to join, but the study was stopped early. The goal was to see if this app…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Botswana study investigates tamoxifen adherence in breast cancer patients
Knowledge-focused TerminatedThis study looked at why some women with breast cancer in Botswana stop taking tamoxifen, a key hormone therapy. Researchers focused on side effects, quality of life, and HIV status. The study was terminated early and only enrolled 10 participants, so findings are limited.
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Brain scan study aims to unlock secrets of consciousness
Knowledge-focused TerminatedThis study tested whether a special type of brain scan (resting state fMRI) could help doctors better understand and predict recovery in patients with disorders of consciousness, such as coma. Nine adults with these conditions were enrolled. The goal was to see if the scans could…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC